Esophageal cancer pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 8: Line 8:
==Pathophysiology==
==Pathophysiology==


The [[esophagus]] is lined by nonkeratinized stratified [[Squamous epithelium|squamous]] [[epithelium]]. This lining is maintained as long as there are no stressors leading to a [[Metaplasia|metaplastic]] change. These stressors may include [[Genetics|genetic]] factors, chronic [[alcoholism]], [[smoking]], ingesting spicy foods and hot liquids frequently,  and [[Gastroesophageal reflux disease|chronic gastroesophageal reflux]]. Eventually, a [[Dysplasia|dysplastic]] change occurs followed by a [[Metaplasia|metaplastic]] change, which may be [[Squamous cell carcinoma|squamous cell]] carcinoma or [[adenocarcinoma]].<ref name="pmid29037468">{{cite journal |vauthors=Quante M, Graham TA, Jansen M |title=Insights into the Pathophysiology of Esophageal Adenocarcinoma |journal=Gastroenterology |volume= |issue= |pages= |year=2017 |pmid=29037468 |doi=10.1053/j.gastro.2017.09.046 |url=}}</ref>  
*The [[esophagus]] is lined by nonkeratinized stratified [[Squamous epithelium|squamous]] [[epithelium]].  
*This lining is maintained as long as there are no stressors leading to a [[Metaplasia|metaplastic]] change.
 
===Esophageal Squamous Cell Carcinoma===
*The risk factors for esophageal squamous cell carcinoma include smoking and alcohol.<ref name="pmid24834141">{{cite journal |vauthors=Napier KJ, Scheerer M, Misra S |title=Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities |journal=World J Gastrointest Oncol |volume=6 |issue=5 |pages=112–20 |year=2014 |pmid=24834141 |pmc=4021327 |doi=10.4251/wjgo.v6.i5.112 |url=}}</ref><ref name="pmid22320939">{{cite journal |vauthors=Mao WM, Zheng WH, Ling ZQ |title=Epidemiologic risk factors for esophageal cancer development |journal=Asian Pac. J. Cancer Prev. |volume=12 |issue=10 |pages=2461–6 |year=2011 |pmid=22320939 |doi= |url=}}</ref>
*Alcohol is able to dissolve fat soluble compounds.
*When alcohol and tabacco are combined they have a synergistic effect and the risk for squamous cell esophageal cancer is higher.
*Tabacco carcinogens such as aromatic amines, nitrosamines and polycyclic hydrocarbons are, therefore, able to penetrate the esophageal epithelium deeper when in the presence of alcohol.
*Alcohol is also able to decrease the metabolic activities of epithelial cells by damaging DNA.
*When the cellular DNA is damaged, the cell can not undergo detoxification and cannot protect itself from oxidative damage.
*Oxidation leads to inflammation of the squamous epithelium.
*Continuous irritation of the epithelium leads to dysplasia and in situ malignant transformation.
 
===Esophageal Adenocarcinoma===
 
*The risk factors of adenocarcinoma of the esophagus include gastroesophageal reflux disease and obesity.<ref name="pmid8578231">{{cite journal |vauthors=Tilanus HW |title=Changing patterns in the treatment of carcinoma of the esophagus |journal=Scand. J. Gastroenterol. Suppl. |volume=212 |issue= |pages=38–42 |year=1995 |pmid=8578231 |doi= |url=}}</ref><ref name="pmid10233832">{{cite journal |vauthors=Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, Kerr D, Young LS |title=Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus |journal=Am. J. Pathol. |volume=154 |issue=4 |pages=965–73 |year=1999 |pmid=10233832 |pmc=1866556 |doi=10.1016/S0002-9440(10)65346-1 |url=}}</ref><ref name="pmid16299787">{{cite journal |vauthors=Koppert LB, Wijnhoven BP, van Dekken H, Tilanus HW, Dinjens WN |title=The molecular biology of esophageal adenocarcinoma |journal=J Surg Oncol |volume=92 |issue=3 |pages=169–90 |year=2005 |pmid=16299787 |doi=10.1002/jso.20359 |url=}}</ref><ref name="pmid8998117">{{cite journal |vauthors=Ireland AP, Clark GW, DeMeester TR |title=Barrett's esophagus. The significance of p53 in clinical practice |journal=Ann. Surg. |volume=225 |issue=1 |pages=17–30 |year=1997 |pmid=8998117 |pmc=1190601 |doi= |url=}}</ref><ref name="pmid23500888">{{cite journal |vauthors=Nieman KM, Romero IL, Van Houten B, Lengyel E |title=Adipose tissue and adipocytes support tumorigenesis and metastasis |journal=Biochim. Biophys. Acta |volume=1831 |issue=10 |pages=1533–41 |year=2013 |pmid=23500888 |pmc=3742583 |doi=10.1016/j.bbalip.2013.02.010 |url=}}</ref>
*The chronic reflux of gastric acid and bile at the gastroesophageal junction leads to the irritation of squamous epithelium lining the esophagus.
*Chronic irritation leads to metaplasia of esophagus.
*The lining of the esophagus changes from non-keratinized stratified [[Squamous epithelium|squamous]] [[epithelium]] to columnar epithelium.
*This condition is called Barrett's esophagus.
*The progression of Barrett metaplasia to adenocarcinoma is associated with several changes in gene structure, gene expression, and protein structure.
*Mutations in PT53 genes and P16 genes along with cell cycle abnormalities and aneuploidy have all been associated with esophageal adenocarcinoma.
*In addition, obesity is implicated in the development of esophageal adenocarcinoma.
*Patients with central obesity tend to have hypertrophied adipocytes and inflammatory cells within their fat deposits.
*This creates a microenvironment within the adipocyte that promotes tumor development through the release of adipokines and cytokines.
*Adipocytes are also able to provide energy to support the tumor's growth.
 


==Pathology==
==Pathology==

Revision as of 19:22, 20 December 2017

Esophageal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Esophageal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal cancer pathophysiology On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal cancer pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal cancer pathophysiology

CDC on Esophageal cancer pathophysiology

Esophageal cancer pathophysiology in the news

Blogs on Esophageal cancer pathophysiology

Directions to Hospitals Treating Esophageal cancer

Risk calculators and risk factors for Esophageal cancer pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Overview

The pathophysiology of esophageal cancer depends on the histological subtype, whether squamous cell carcinoma or adenocarcinoma.

Pathophysiology

Esophageal Squamous Cell Carcinoma

  • The risk factors for esophageal squamous cell carcinoma include smoking and alcohol.[1][2]
  • Alcohol is able to dissolve fat soluble compounds.
  • When alcohol and tabacco are combined they have a synergistic effect and the risk for squamous cell esophageal cancer is higher.
  • Tabacco carcinogens such as aromatic amines, nitrosamines and polycyclic hydrocarbons are, therefore, able to penetrate the esophageal epithelium deeper when in the presence of alcohol.
  • Alcohol is also able to decrease the metabolic activities of epithelial cells by damaging DNA.
  • When the cellular DNA is damaged, the cell can not undergo detoxification and cannot protect itself from oxidative damage.
  • Oxidation leads to inflammation of the squamous epithelium.
  • Continuous irritation of the epithelium leads to dysplasia and in situ malignant transformation.

Esophageal Adenocarcinoma

  • The risk factors of adenocarcinoma of the esophagus include gastroesophageal reflux disease and obesity.[3][4][5][6][7]
  • The chronic reflux of gastric acid and bile at the gastroesophageal junction leads to the irritation of squamous epithelium lining the esophagus.
  • Chronic irritation leads to metaplasia of esophagus.
  • The lining of the esophagus changes from non-keratinized stratified squamous epithelium to columnar epithelium.
  • This condition is called Barrett's esophagus.
  • The progression of Barrett metaplasia to adenocarcinoma is associated with several changes in gene structure, gene expression, and protein structure.
  • Mutations in PT53 genes and P16 genes along with cell cycle abnormalities and aneuploidy have all been associated with esophageal adenocarcinoma.
  • In addition, obesity is implicated in the development of esophageal adenocarcinoma.
  • Patients with central obesity tend to have hypertrophied adipocytes and inflammatory cells within their fat deposits.
  • This creates a microenvironment within the adipocyte that promotes tumor development through the release of adipokines and cytokines.
  • Adipocytes are also able to provide energy to support the tumor's growth.


Pathology

Gross pathology

Squamous cell carcinoma or adenocarcinoma of the esophagus may appear as:[8]

Microscopic pathology

Nuclear atypia of malignancy:

Squamous cell carcinoma:

Esophageal squamous cell carcinoma by Nephron - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=31284085

Adenocarcinoma

Esophageal adenocarcinoma by Nephron - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=12475495

References

  1. Napier KJ, Scheerer M, Misra S (2014). "Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities". World J Gastrointest Oncol. 6 (5): 112–20. doi:10.4251/wjgo.v6.i5.112. PMC 4021327. PMID 24834141.
  2. Mao WM, Zheng WH, Ling ZQ (2011). "Epidemiologic risk factors for esophageal cancer development". Asian Pac. J. Cancer Prev. 12 (10): 2461–6. PMID 22320939.
  3. Tilanus HW (1995). "Changing patterns in the treatment of carcinoma of the esophagus". Scand. J. Gastroenterol. Suppl. 212: 38–42. PMID 8578231.
  4. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, Kerr D, Young LS (1999). "Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus". Am. J. Pathol. 154 (4): 965–73. doi:10.1016/S0002-9440(10)65346-1. PMC 1866556. PMID 10233832.
  5. Koppert LB, Wijnhoven BP, van Dekken H, Tilanus HW, Dinjens WN (2005). "The molecular biology of esophageal adenocarcinoma". J Surg Oncol. 92 (3): 169–90. doi:10.1002/jso.20359. PMID 16299787.
  6. Ireland AP, Clark GW, DeMeester TR (1997). "Barrett's esophagus. The significance of p53 in clinical practice". Ann. Surg. 225 (1): 17–30. PMC 1190601. PMID 8998117.
  7. Nieman KM, Romero IL, Van Houten B, Lengyel E (2013). "Adipose tissue and adipocytes support tumorigenesis and metastasis". Biochim. Biophys. Acta. 1831 (10): 1533–41. doi:10.1016/j.bbalip.2013.02.010. PMC 3742583. PMID 23500888.
  8. Sugarbaker, David (2015). Adult chest surgery. New York: McGraw-Hill Education. ISBN 0071781897.
  9. "Squamous cell carcinoma of the esophagus".
  10. "Esophageal adenocarcinoma".


Template:WikiDoc Sources